Non-operative management after chemoradiotherapy plus consolidation or sandwich (induction with bevacizumab and consolidation) chemotherapy in patients with locally advanced rectal cancer: a multicentre, randomised phase II trial (NOMINATE trial)
Takashi Akiyoshi(The Japanese Society of Gastroenterological Surgery), Tsuyoshi Konishi(Japanese Foundation For Cancer Research), Yukiharu Hiyoshi(Japanese Foundation For Cancer Research), Koji Okabayashi(Keio University), Tetsuro Tominaga(Nagasaki University Hospital), Naoki Ishizuka(Iwate Medical University), Shimpei Matsui(Keio University), Toshiki Mukai(Japanese Foundation For Cancer Research), Senzo Taguchi(Japanese Foundation For Cancer Research), Shigeo Toda(Toranomon Hospital), Tomohiro Yamaguchi(Japanese Foundation For Cancer Research), Akiko Chino(Japanese Foundation For Cancer Research), Yosuke Fukunaga(Japanese Foundation For Cancer Research), Toshiya Nagasaki(Japanese Foundation For Cancer Research), Shuichiro Matoba(Toranomon Hospital), Kensei Yamaguchi(Japanese Foundation For Cancer Research), Masashi Ueno(Toranomon Hospital), Takashi Nonaka(Nagasaki University), Hiroya Kuroyanagi(Toranomon Hospital), Eiji Shinozaki(Japanese Foundation For Cancer Research), Makiko Hiratsuka(Japanese Foundation For Cancer Research)
Cited by 14
Related Papers
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial
|The Lancet Oncology|2021|411
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
|Nature Medicine|2020|366